185 related articles for article (PubMed ID: 4917579)
1. Neurophysiological and biochemical aspects in the action of antidepressant drugs.
Benesová O
Act Nerv Super (Praha); 1970; 12(3):226-34. PubMed ID: 4917579
[No Abstract] [Full Text] [Related]
2. [Some current aspects of antidepressive therapy].
Predescu V; Vianu I
Neurol Psihiatr Neurochir; 1967; 12(6):485-94. PubMed ID: 5593224
[No Abstract] [Full Text] [Related]
3. A choice--drugs or electroshock for depression.
Koutsky CD
Dis Nerv Syst; 1966 Dec; 27(12):806-7. PubMed ID: 5954741
[No Abstract] [Full Text] [Related]
4. [Psychotherapeutic and pharmacological treatment of depression. Introduction. Concepts, psychodynamical aspects].
De Mendonca Uchóa D; Forlenza Neto O; Levy Júnior M; De Camargo Neto JM
J Bras Psiquiatr; 1969; 18(3):203-39. PubMed ID: 4946382
[No Abstract] [Full Text] [Related]
5. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia].
Scala A
Osp Psichiatr; 1967; 35(4):501-34. PubMed ID: 5607254
[No Abstract] [Full Text] [Related]
6. Serotonin, and its effects on the pituitary-adrenal axis in depression.
Stern H
Chic Med Sch Q; 1970; 29(1):24-30. PubMed ID: 4911289
[No Abstract] [Full Text] [Related]
7. Pyrazidol, a new drug with antidepressant properties.
Mashkovsky MD; Andreyeva NI
Ann Ist Super Sanita; 1978; 14(1):43-8. PubMed ID: 573978
[TBL] [Abstract][Full Text] [Related]
8. MAO inhibition and antidepressant activity.
Feldstein A; Hoagland H; Rivera Oktem M; Freeman H
Int J Neuropsychiatry; 1965 Aug; 1(4):384-7. PubMed ID: 5324597
[No Abstract] [Full Text] [Related]
9. [Drug therapy of depressions and depression research].
Pöldinger W
Wien Med Wochenschr; 1967 Jan; 117(3):69-75. PubMed ID: 4870923
[No Abstract] [Full Text] [Related]
10. Clinical application of antidepressant agents in disabled and rehabilitation patients.
Rosen S; Martorano J
Arch Phys Med Rehabil; 1965 Nov; 46(11):739-44. PubMed ID: 4221144
[No Abstract] [Full Text] [Related]
11. [Introductory remarks: on the status of therapy with antidepressive agents].
Coper H; Hippius H; Selbach H
Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:835+. PubMed ID: 4895490
[No Abstract] [Full Text] [Related]
12. [Management of endogenous depressions using psychopharmacologic agents].
Kielholz P; Pöldinger W
Dtsch Med Wochenschr; 1968 Apr; 93(14):701-4. PubMed ID: 5660916
[No Abstract] [Full Text] [Related]
13. Depressive disorders.
Hordern A
Practitioner; 1974 Oct; 213(1276 SPEC NO):560-73. PubMed ID: 4156404
[No Abstract] [Full Text] [Related]
14. [Therapy with antidepressive and tranquilizing agents].
Barocka A
Fortschr Med; 1984 Aug; 102(31-32):775-9. PubMed ID: 6148296
[TBL] [Abstract][Full Text] [Related]
15. [The action spectra of psychopharmacological drugs].
Poeldinger W
Clin Ter; 1968 Jan; 44(2):103-13. PubMed ID: 5741268
[No Abstract] [Full Text] [Related]
16. [Theoretical principles of therapy using neuroleptic and antidepressive drugs].
Matussek N
Med Welt; 1976 Mar; 27(11):508-11. PubMed ID: 1263788
[No Abstract] [Full Text] [Related]
17. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
18. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs.
Cryan JF; Dalvi A; Jin SH; Hirsch BR; Lucki I; Thomas SA
J Pharmacol Exp Ther; 2001 Aug; 298(2):651-7. PubMed ID: 11454927
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.
Schildkraut JJ; Schanberg SM; Breese GR; Kopin IJ
Am J Psychiatry; 1967 Nov; 124(5):600-8. PubMed ID: 4383104
[No Abstract] [Full Text] [Related]
20. [New studies on the use of antidepressants].
Deniker P; Loo H; Zarifian E
Ann Med Psychol (Paris); 1980 Jan; 138(1):103-13. PubMed ID: 6104461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
